Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 20/20 | 0.63 |
| ▸ | EGFR | P00533 | 1/20 | 0.63 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.63 |
| ▸ | CRYZ | Q08257 | 1/20 | 0.63 |
| ▸ | VAT1 | Q99536 | 1/20 | 0.63 |
| ▸ | RTN4 | Q9NQC3 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16636979 | 0.90 | KRAS (0.78) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL21415542 | 0.87 | KRAS (0.64) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL29765671 | 0.82 | KRAS (0.69) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16646900 | 0.82 | KRAS (0.69) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16647011 | 0.81 | KRAS (0.63) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL29765643 | 0.81 | KRAS (0.63) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL29765758 | 0.81 | KRAS (0.80) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16646906 | 0.81 | KRAS (0.80) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL19681380 | 0.80 | KRAS (0.63) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL18128605 | 0.79 | KRAS (0.75) | KRASEGFRHMOX2CRYZVAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017100546-A1 | METHODS FOR PREPARATION OF QUINAZOLINE DERIVATIVES | ARAXES PHARMA LLC (US) | 2017-06-15 | — | — | WO | disclosed |